Drug Discovery & Research
Digital Pathology Alliance Aims to Streamline AI-Powered Cancer Diagnostic Development
Imagene AI's integration with Proscia's platform creates end-to-end pathway for pharmaceutical companies to develop companion diagnostics from discovery through clinical deployment.
Health AI Central Editorial Team·August 20, 2026
Policy & Regulation
FDA Grants Proscia Regulatory Fast Lane to Solve Digital Pathology's Interoperability Crisis
New clearance with Predetermined Change Control Plan allows platform to add scanner compatibility without repeated FDA submissions, addressing a major barrier to digital pathology adoption.
Health AI Central Editorial Team·August 14, 2026
Clinical AI
AI Pathology Tool Catches Diagnostic Errors in 5% of Prostate Biopsies in Major NHS Trial
Real-world study across three UK health trusts shows Tempus's AI software reduced turnaround times by nearly a day while prompting clinically significant diagnostic changes in over 1% of cases.
Health AI Central Editorial Team·July 17, 2026